The company said revenue for Q3 was flat from a year earlier at $54.9 billion, GAAP operating earnings were $730 million, and non-GAAP operating earnings rose 21% to $807 million.

1. 01

   The company said revenue for Q3 was flat from a year earlier at $54.9 billion, GAAP operating earnings were $730 million, and non-GAAP operating earnings rose 21% to $807 million.

2. 02

   The company said GAAP diluted EPS for Q3 was $2.10, and non-GAAP diluted EPS rose 13% to $2.35. It said revenue increased 19% excluding the impact of the previously communicated customer contract expiration.

3. 03

   Cardinal Health raised and narrowed its non-GAAP diluted EPS guidance for fiscal 2025 to $8.05 to $8.15, from $7.85 to $8.00 previously, the company said.

4. 04

   Cardinal Health said it completed its acquisition of Advanced Diabetes Supply Group on April 1 and completed a $375M accelerated share repurchase program during Q3.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.